BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Diagnosis
48 results:

  • 1. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
    Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
    [No Abstract]    [Full Text] [Related]  

  • 2. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
    Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
    Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
    Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
    Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
    Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
    JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging Findings in Cirrhotic liver: Pearls and Pitfalls for diagnosis of Focal Benign and Malignant Lesions.
    Liu X; Tan SBM; Awiwi MO; Jang HJ; Chernyak V; Fowler KJ; Shaaban AM; Sirlin CB; Furlan A; Marks RM; Elsayes KM
    Radiographics; 2023 Sep; 43(9):e230043. PubMed ID: 37651277
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant.
    Bustamante D; Abadie J
    Lab Med; 2024 May; 55(3):391-393. PubMed ID: 37477894
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant ctnnb1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
    Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
    Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
    Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
    Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
    Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma.
    Pallerla SR; Hoan NX; Rachakonda S; Meyer CG; Van Tong H; Toan NL; Linh LTK; Giang DP; Kremsner PG; Bang MH; Song LH; Velavan TP
    BMC Med Genomics; 2022 Nov; 15(1):235. PubMed ID: 36345011
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma.
    Lee HW; Kim E; Cho KJ; Park HJ; Seo J; Lee H; Baek E; Choi JR; Han KH; Lee ST; Park JY
    Liver Int; 2022 Oct; 42(10):2317-2326. PubMed ID: 35776657
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNIcancer, SFCD, SFED, SFRO, ACHBT, SFR).
    Benech N; Bonvalot S; Dufresne A; Gangi A; Le Péchoux C; Lopez-Trabada-Ataz D; Meurgey A; Nicolas N; Orbach D; Penel N; Salas S; Saurin JC; Walter T; Lecomte T; Bouché O; ; ; ; ; ; ; ; ; ;
    Dig Liver Dis; 2022 Jun; 54(6):737-746. PubMed ID: 35508462
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Yoon JK; Choi JY; Rhee H; Park YN
    Eur Radiol; 2022 Aug; 32(8):5119-5133. PubMed ID: 35258675
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. β-Catenin signaling in hepatocellular carcinoma.
    Xu C; Xu Z; Zhang Y; Evert M; Calvisi DF; Chen X
    J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166233
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice.
    Desjonqueres E; Campani C; Marra F; Zucman-Rossi J; Nault JC
    Liver Int; 2022 Mar; 42(3):492-506. PubMed ID: 34982503
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer.
    Lin J; Peng X; Dong K; Long J; Guo X; Li H; Bai Y; Yang X; Wang D; Lu X; Mao Y; Sang X; Ji X; Zhao H; Liang H
    Nat Commun; 2021 Aug; 12(1):4753. PubMed ID: 34362903
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic landscape of hepatocarcinogenesis.
    Shibata T
    J Hum Genet; 2021 Sep; 66(9):845-851. PubMed ID: 33958712
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.